Pfizer
PFE
PFE
2,374 hedge funds and large institutions have $176B invested in Pfizer in 2019 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 923 increasing their positions, 1,101 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,374
Holders Change
-13
Holders Change %
-0.54%
% of All Funds
51.64%
Holding in Top 10
199
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1%
% of All Funds
4.33%
New
92
Increased
923
Reduced
1,101
Closed
74
Calls
$1.74B
Puts
$1.35B
Net Calls
+$392M
Net Calls Change
+$151M
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$18.5B |
| 2 |
2
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
$255M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$4.05B |
| 4 |
4
Goldman Sachs
New York
|
$1.74B |
| 5 |
MWNA
5
Marshall Wace North America
New York
|
$4.92M |